| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| GNMA REMIC SER 2012-128 | PURCHASE | 2020-05 | 882,281 | 880,697 | 1,584 | |||||
| GNMA REMIC SER 2012-136 | PURCHASE | 2020-05 | 2,064,032 | 2,103,877 | -39,845 | |||||
| AVANOS MEDICAL INC | PURCHASE | 2020-09 | 13,770 | 14,442 | -672 | |||||
| TEVA PHARMACEUTICALS | PURCHASE | 2020-09 | 44,043 | 266,692 | -222,649 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ABBVIE INC | 340,388 | 544,612 |
| AVANOS MEDICAL INC | ||
| BECTON DICKINSON & CO | 578,031 | 1,077,604 |
| JOHNSON & JOHNSON | 608,356 | 857,411 |
| KIMBERLY CLARK CORP | 1,043,165 | 1,314,302 |
| PROCTER & GAMBLE CO | 2,309 | 4,100 |
| TEVA PHARMACEUTICAL | ||
| 3M COMPANY | 612,068 | 672,236 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 52 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| WIRE FEE | 25 | 25 |